5/2
07:21 am
abt
BrioHealth wins FDA nod to trial BrioVAD ventricular assist device [Yahoo! Finance]
Low
Report
BrioHealth wins FDA nod to trial BrioVAD ventricular assist device [Yahoo! Finance]
5/2
04:21 am
abt
Global RTD Beverages Market Research 2024-2031: Increasing Focus on Health and Wellness, Rising Demand for Clean-Label Products, Product Premiumization [Yahoo! Finance]
Low
Report
Global RTD Beverages Market Research 2024-2031: Increasing Focus on Health and Wellness, Rising Demand for Clean-Label Products, Product Premiumization [Yahoo! Finance]
5/1
10:43 am
abt
Global Functional Dyspepsia Drug Market to reach a valuation of US$ 16.4 billion by 2034, Future Market Insights, Inc. Projection [Yahoo! Finance]
Low
Report
Global Functional Dyspepsia Drug Market to reach a valuation of US$ 16.4 billion by 2034, Future Market Insights, Inc. Projection [Yahoo! Finance]
5/1
07:25 am
abt
Legionella Testing Global Market Report 2024: Increasing Legionella Testing Demand From Hospitality Sector and Rising Incidence of Pneumonia and Legionella-related Illnesses [Yahoo! Finance]
Low
Report
Legionella Testing Global Market Report 2024: Increasing Legionella Testing Demand From Hospitality Sector and Rising Incidence of Pneumonia and Legionella-related Illnesses [Yahoo! Finance]
4/30
09:23 am
abt
Global Drug-Eluting Stents Strategic Research Report 2024-2030: Biodegradable Polymers Represent Promising Developments, Offering the Potential for Enhanced Biocompatibility [Yahoo! Finance]
Low
Report
Global Drug-Eluting Stents Strategic Research Report 2024-2030: Biodegradable Polymers Represent Promising Developments, Offering the Potential for Enhanced Biocompatibility [Yahoo! Finance]
4/29
09:20 am
abt
Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee [Yahoo! Finance]
Low
Report
Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee [Yahoo! Finance]
4/29
09:00 am
abt
Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Low
Report
Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
4/26
03:18 pm
abt
ABT, DHR, DXCM: Which “Strong Buy” Healthcare Stock Has More Upside? [Yahoo! Finance]
Low
Report
ABT, DHR, DXCM: Which “Strong Buy” Healthcare Stock Has More Upside? [Yahoo! Finance]
4/26
07:20 am
abt
Global Penicillin Analysis Report 2024: Market to Grow by $2.82 Billion During 2023-2028, Driven by M&As, and Special Regulatory Designations Driving the Quality of Penicillin [Yahoo! Finance]
Low
Report
Global Penicillin Analysis Report 2024: Market to Grow by $2.82 Billion During 2023-2028, Driven by M&As, and Special Regulatory Designations Driving the Quality of Penicillin [Yahoo! Finance]
4/26
05:05 am
abt
Whey Protein Market To Reach USD 16.8 Billion By 2032, Says DataHorizzon Research [Yahoo! Finance]
Low
Report
Whey Protein Market To Reach USD 16.8 Billion By 2032, Says DataHorizzon Research [Yahoo! Finance]
4/26
02:32 am
abt
Edwards Lifesciences first-quarter profit beats estimates on heart devices strength [Reuters]
Low
Report
Edwards Lifesciences first-quarter profit beats estimates on heart devices strength [Reuters]
4/25
01:40 pm
abt
Europe High Pressure Non-Compliant Balloon Catheter Market Size to Worth USD 1,801.5 by 2032: Astute Analytica [Yahoo! Finance]
Low
Report
Europe High Pressure Non-Compliant Balloon Catheter Market Size to Worth USD 1,801.5 by 2032: Astute Analytica [Yahoo! Finance]
4/25
05:38 am
abt
Global Bionic Devices Industry Research, 2023-2024 & 2030: Addressing Diverse Healthcare Needs Worldwide to Sustain Growth and Fuel Develoments [Yahoo! Finance]
Low
Report
Global Bionic Devices Industry Research, 2023-2024 & 2030: Addressing Diverse Healthcare Needs Worldwide to Sustain Growth and Fuel Develoments [Yahoo! Finance]
4/24
08:07 am
abt
Valcare Medical, Inc. Announces Corporate Restructuring and Appointment of New CEO [Yahoo! Finance]
Low
Report
Valcare Medical, Inc. Announces Corporate Restructuring and Appointment of New CEO [Yahoo! Finance]
4/24
07:21 am
abt
Europe In-Vitro Diagnostics (IVD) Markets, 2023-2024 & 2029 with Abbott, bioMerieux, Danaher, Hoffmann-La Roche, Bio-Rad, Siemens Healthineers, Thermo Fisher Scientific, and Diasorin Dominating [Yahoo! Finance]
Low
Report
Europe In-Vitro Diagnostics (IVD) Markets, 2023-2024 & 2029 with Abbott, bioMerieux, Danaher, Hoffmann-La Roche, Bio-Rad, Siemens Healthineers, Thermo Fisher Scientific, and Diasorin Dominating [Yahoo! Finance]
4/24
04:29 am
abt
Autoimmune Collaboration and Licensing Deals Report 2024: Provides Details of 882 Autoimmune Deals Dating Back to 2016 by Company, Headline Value, Therapeutic Area and Technology Type [Yahoo! Finance]
Low
Report
Autoimmune Collaboration and Licensing Deals Report 2024: Provides Details of 882 Autoimmune Deals Dating Back to 2016 by Company, Headline Value, Therapeutic Area and Technology Type [Yahoo! Finance]
4/24
04:29 am
abt
Drug Discovery Global Market Report and Growth Forecasts 2023-2030: Collaborative Research Models, Personalized Medicine and Repurposing Existing Drugs Present Key Opportunities [Yahoo! Finance]
Low
Report
Drug Discovery Global Market Report and Growth Forecasts 2023-2030: Collaborative Research Models, Personalized Medicine and Repurposing Existing Drugs Present Key Opportunities [Yahoo! Finance]
4/24
04:06 am
abt
Rapid Influenza Diagnostic Test Market to Reach US$ 2.61 Billion by 2034: Fact.MR Report [Yahoo! Finance]
Low
Report
Rapid Influenza Diagnostic Test Market to Reach US$ 2.61 Billion by 2034: Fact.MR Report [Yahoo! Finance]
4/24
02:50 am
abt
Reckitt Sales Defy Forecast After Baby Formula Legal Row [BNN Bloomberg (Canada)]
Low
Report
Reckitt Sales Defy Forecast After Baby Formula Legal Row [BNN Bloomberg (Canada)]
4/24
01:32 am
abt
Abbott Laboratories (NYSE: ABT) had its "buy" rating re-affirmed by analysts at Raymond James. They now have a $124.00 price target on the stock.
Low
Report
Abbott Laboratories (NYSE: ABT) had its "buy" rating re-affirmed by analysts at Raymond James. They now have a $124.00 price target on the stock.
4/22
08:40 am
abt
Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Barclays PLC from $141.00 to $140.00. They now have an "overweight" rating on the stock.
Low
Report
Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Barclays PLC from $141.00 to $140.00. They now have an "overweight" rating on the stock.
4/22
08:04 am
abt
Should You Pick Abbott Stock At $105 After An Upbeat Q1? [Forbes]
Low
Report
Should You Pick Abbott Stock At $105 After An Upbeat Q1? [Forbes]
4/22
01:34 am
abt
Why I Believe Abbott Is Much Better Positioned In Today's Rising Inflation Scenario [Seeking Alpha]
Low
Report
Why I Believe Abbott Is Much Better Positioned In Today's Rising Inflation Scenario [Seeking Alpha]
4/22
01:12 am
abt
D-dimer Testing Market to hit USD 2 Bn by 2032, says Global Market Insights Inc. [Yahoo! Finance]
Low
Report
D-dimer Testing Market to hit USD 2 Bn by 2032, says Global Market Insights Inc. [Yahoo! Finance]
4/20
09:14 am
abt
We Think Some Shareholders May Hesitate To Increase Abbott Laboratories' (NYSE:ABT) CEO Compensation [Yahoo! Finance]
Low
Report
We Think Some Shareholders May Hesitate To Increase Abbott Laboratories' (NYSE:ABT) CEO Compensation [Yahoo! Finance]